A-Z

Systemic Vasculitis

Making decisions about increasing, reducing or changing systemic vasculitis medication

This page is about:
  • Making decisions about systemic vasculitis medication
  • How infection risk affects systemic vasculitis treatment decisions 
  • Making decisions about reducing reliance on steroids 
The aim of treatment is to reduce medication to the lowest level of immunosuppression needed to keep the vasculitis suppressed.

Making decisions about systemic vasculitis medication

Sometimes people were too ill with vasculitis to take part in decisions about their treatment. 
 
 

Claudia had kidney dialysis while she was in intensive care with vasculitis but wasn’t aware of this.

Claudia had kidney dialysis while she was in intensive care with vasculitis but wasn’t aware of this.

Age at interview: 39
Sex: Female
Age at diagnosis: 37
Anti-GBM with ANCA
SHOW TEXT VERSION
PRINT TRANSCRIPT

Apparently, they took me into ICU, [sighs] according to him, my, that night, the first night there, my heart stopped twice. It was very, so those days, I can see them through his perspective, through what he remembers. And he even, like, when we go there, he even has people, you know? So once, I remember we were walking down those corridors and he stopped, a short gentleman, he was like, “Look, there she is, you know, she’s alive, she’s walking in front of you.” [looks confused and laughs] And I don’t, I don’t remember that person. Apparently, that was the person that was with me in ICU. In ICU they’re very, it’s like, one nurse, one patient, they’re very organised like that.

[Sighs] What I remember from ICU is, I think after I woke up, I saw my mother. I remember I was thirsty, initially they didn’t want to give me water, they just put some bit of water on a sponge, and they did like this on my lips [gestures]. I remember having an oxygen mask on my face and they were saying, like, “You should sleep,” and I was like, “I can’t sleep because it’s too cold too in this oxygen mask.” A lot of things going on, a lot of movement, but I couldn’t see a lot. I could just hear.

Anyway, after I think two nights I remember sleeping there, I moved to a different, to a different ward and things were different. There was a lot of, so after, after they… Apparently, I also got dialysis when I was in ICU, according to my husband. I don’t remember. I had some in here, [points to neck] I had some wires, some, I don’t know, I think they… Who knows what they did during that time, but here, like, I had three or four things? That was again, really weird when I actually realised. I didn’t know but at some point, I actually realised that there’s [points to neck].

 
Even when people were well enough to make decisions, Gail was among those who had noticed vasculitis treatment was - to an extent - just “what we have to do.” Claudia also emphasised that “trial and error” with different immunosuppressants is involved to find what best suits each individual. It was not always clear to us how much of a part people played in treatment decisions. However, those who did tell us that their consultants discuss options with them felt it was important. 
 
 

Jeremy joined a drug trial as part of his vasculitis treatment after his consultant discussed the options.

Jeremy joined a drug trial as part of his vasculitis treatment after his consultant discussed the options.

Age at interview: 72
Sex: Male
Age at diagnosis: 66
AAV (MPA)
SHOW TEXT VERSION
PRINT TRANSCRIPT

And he discussed the options, which were either cyclophosphamide or rituximab, and explained that the cyclophosphamide was a long-established treatment, known to be very effective but could have a lot of unpleasant side-effects. Whereas rituximab was a much newer drug and that was – so it wasn’t as, it wasn’t as certain to be effective, and, but it would definitely have fewer, possibly no side-effects. So, my response was simply to say, “Well look, if we go with the one that’s more effective, the cyclophosphamide, but I find I can’t tolerate the side-effects, can we stop that and switch to the rituximab?” So, he said “yes,” in which case in my view, it was a no-brainer, one goes for the one that is proven.

So, we went on to the cyclophosphamide and he explained that in parallel with that, one would normally take steroids as well. He’d explained the, you know, the two stages of the treatment first in its initial treatment to hit the vasculitis hard, to try and suppress it, and then to be followed by the maintenance therapy that tries to just keep it under, under control.

He’d obviously also explained that there was no cure for it because, so far, research had not found out what caused the problem. But again, he explained also, and I’m sorry I’m doing this sort of in reverse order, but he explained how it worked. What it did was cause the immune system to attack oneself rather than to attack external infections, so the requirement of all this treatment was basically to suppress the immune system.

Now, in talking about normally going on to steroids, he then spoke about a trial that was underway with an alternative to steroids, because again he explained that steroids have some nasty side-effects. So he was, had some involvement with this new trial of a new drug, and would I be interested in going on that? So, I asked the same question: if we go on that and we find it’s not working, can we switch to the steroids? You know, and again, he said, “Yes, we can. We can stop the trial at any time and go on to steroids.” So, I said, “In that case, we’ll go on to the trial.”

 

Diane thought she might need a biologic drug, but her vasculitis consultant suggested switching from oral methotrexate to injections.

Diane thought she might need a biologic drug, but her vasculitis consultant suggested switching from oral methotrexate to injections.

Age at interview: 39
Sex: Female
Age at diagnosis: 30
Takayasu arteritis
SHOW TEXT VERSION
PRINT TRANSCRIPT

But, overall, my fatigue was improving. I was going, “Look, if I can just get back to work…” Then when I switched from the oral methotrexate to the injections, I couldn’t believe the difference. The difference was like night and day. I, my symptoms, my side effects of taking medication on a Sunday night could have lasted to a Thursday, so I had no time to work. On a Monday, I felt absolutely awful, whereas when I had, took the injections and they started to work, they, I got more... had less side effects, they lasted, you know, on a Monday, sometimes, or being a wee bit dizzy and a wee bit, I would call myself dopey. [laughs] I’m not really, you know, I couldn’t drive, or I couldn’t make a decision, and I could, you could maybe say words back to front or not think of the word that you were wanting to say [laughs]. That’s just how you feel, you don’t feel in control of your own body on the Monday, but I could function to a certain degree, which was brilliant, and then I was able to go to work on a Tuesday, Wednesday and a Thursday, you know, and…

The other good thing about the injection - which I wasn’t aware of at the time - was it isn’t absorbed by the liver; it goes straight into the bloodstream. So, the efficacy of it is actually higher. So, you actually, I needed less, so I was taking 25 milligrams of the tablets and I only needed 20 milligrams of the injection, but the 20 milligrams of the injection was, I think, is it like, the tablet says 50 per cent absorbed, whereas the, the injection is maybe 70 per cent absorbed.

So it was, it was magic. And I don’t know why it took… my team here in Northern Ireland told me I couldn’t go on to it because they were worried about infection at the injection site. And with the warfarin there would be a lot of bruising. Supposedly. But my specialist in England told me that that was a load of nonsense, basically [laughs]. And I couldn’t believe it was like night, night or night and day.

 

After reducing her mycophenolate dose as agreed, Gail’s vasculitis (“Churg”) has flared. She wasn’t able to discuss this with her usual consultant and is now unsure what to do.

Text only
Read below

After reducing her mycophenolate dose as agreed, Gail’s vasculitis (“Churg”) has flared. She wasn’t able to discuss this with her usual consultant and is now unsure what to do.

Age at interview: 52
Sex: Female
Age at diagnosis: 50
AAV (EGPA)
HIDE TEXT
PRINT TRANSCRIPT

So maybe again that’s why, because when I was at the clinic, I said to the consultant that I spoke to, I said, “Look, obviously my, I’m wheezing a bit more and I’m still getting the redness at night,” that’s actually new since coming off the mycophenolate a bit as well, my feet go, my legs and my feet go scarlet, which is obviously the vasculitis rash. Respiratory, slight popping, slight, just slight changes to the, to my ears and sinuses.

So I said to him…

“So all I’m really needing to know at the minute is if, because I’m having these symptoms, it’s not showing, my blood results have gone up a bit but not, nothing to worry about,” so I said, “So if my blood results are not showing any great change but I’m having these,” and actually since seeing him [laughs] it’s got a bit worse, my wheezing at times, but it’s no bad today, which is good. But I say, “I’m trying to figure out if that means that Churg is active or if it’s just going to be symptoms that I’m going to have,” and he said, “No, it’s active,” he said, “It is active,” so.

And that, when I came away from that I thought, “Right, it’s active,” so it’s a bit, again, it’s a bit, scary's maybe too big a word, but it’s a bit of a concern because you think to yourself, “It’s there again,” you know, and should I allow it to, to be a bit active or should I say to [my usual vasculitis consultant], “Look, I’m actually a bit concerned about this,” and for him to then say, because I know he would say, “Let’s go back up the mycophenolate again,” and I would feel great again, I know I would because I did before, well I’m saying I know I would, I hope I would [laughs].

How infection risk affects systemic vasculitis treatment decisions

People told us that there is a complicated relationship between vasculitis, the medication used to treat it, and infections.
 
 

Because infections trigger her vasculitis flares, Mo’s first “line of action” is an antibiotic.

Because infections trigger her vasculitis flares, Mo’s first “line of action” is an antibiotic.

Age at interview: 60
Sex: Female
Age at diagnosis: 43
AAV (GPA)
SHOW TEXT VERSION
PRINT TRANSCRIPT

And you’ve said it’s the unpredictability that’s really hard to deal with because, presumably - from what you’ve said - when it flares, there’s nothing that you can say has led to it flaring, it just happens.

Well, a lot of the time, infection can lead to it, okay? And that’s why I have the antibiotics, okay? So, if somebody’s had something in the house, they’re not feeling too well, they’ve been infective, you think “Oh, that might be it.” So, a lot of the time, it’s an infection. And that’s why I try, I try the antibiotics, try the steroids up. If that doesn’t work, well it definitely is a flare, but it’s often – it can be triggered by an infection, this is the problem. And we get [inaudible] immune system. So bad, like last September I was away, I got bitten by horseflies, oh, it was multiple, it was awful. Ended up, we were out in Braemar in the caravan, I had to come back in on Saturday and end up in A&E, massive cellulitis, I mean massive. They said to me “Double your dose of amoxicillin. Ten days. If it doesn’t settle down and it’s not feeling better in about three or four days, you’ll have to come and get IV antibiotics.” It was really, really nasty cellulitis. So again, that was from a bite, an insect bite, and it just [makes phew sound] massive.

So infection is often a trigger and that’s why I have antibiotics handy, because that’s one of my first lines, “Okay, just try an antibiotic,” see if it knocks it on the head. If it doesn’t, steroids, okay, doesn’t, okay, we need more. So, there’s a certain sort of, I don’t know, line of action I would take. So, a lot of the time it, it is infection, and that’s why, it sounds awful, maybe I do stay away from people. Because I don’t want infections [laughs]. You know, subconsciously? You know, people carry bugs, I’m very, and people around me are very wary and the family are very wary, my in-laws, you know? Don’t, mm. I think it’s caused a bit of isolation, [laughs] to tell you the truth. People don’t want to come near me. For fear of giving me something if they’ve got something. A lot of that goes on. Yeah. Mhm. Yeah.

 

While infections are “a threat,” Melissa decided she needs immunosuppression to “have a life.”

While infections are “a threat,” Melissa decided she needs immunosuppression to “have a life.”

Age at interview: 22
Sex: Female
Age at diagnosis: 18
Behçet’s syndrome
SHOW TEXT VERSION
PRINT TRANSCRIPT

So, at the point that happened, they took me off the immunosuppressants and sort of said that the Behcet’s was less of a threat than the infections at that point, and I still had a lot of the immunosuppressants in my system, they said it would take about six months for me to sort of get back to the level that I was before.

So, I went back to the Behcet’s Centre. We had a lot of in-depth discussions about what this meant for my life, and yeah, I quite quickly decided that I was not happy to be without some level of immunosuppression? I wasn’t going to go back to that place that I was as a teenager, that Behcet’s ruled my entire life, and that I have an appreciation that there was some risk involved, that, that I wouldn’t have a life if I didn’t take that risk, because I’d spend so much of the time having flares, being bed bound, not being able to speak or eat, that I just wasn’t willing to go back to that place. Because of course that in itself makes me at risk for infections, so yeah.

So, they decided to start me on biologic therapy, which was sort of a last resort treatment because it’s very expensive, but so far, I’ve done really quite well on it. I inject myself every other week, it’s sort of become part of routine, for someone that’s undergone a lot of medical procedures it’s not a big deal.

And I’ve had a couple of infections, and I’ve had one very serious infection, but aside from that I’m quite happy and sort of when I, when I commit to something now it sort of, I tell people that, “Look, I’ve got this condition, I’m prone to infections, things happen, I end up in hospital unexpectedly, it’s not an issue of my commitment to something, it’s just sort of the way I am.” And I feel like the effort I put into things otherwise makes up for it a lot?

 
Like Mo and Melissa, infections were a real problem for some of the people we spoke to. Sharon developed pneumonia and E. coli. It took her a long time to recover and meant she needed emergency rather than planned kidney dialysis. 

Making decisions about reducing reliance on steroids

It was usual for people to be prescribed high doses of steroids both initially and following a relapse, often alongside other medication to suppress the immune system. Due to the long-term side effects of steroids, the dose needs to be reduced over time. However, as this steroid “tapering” also has side effects, it has to be done gradually. Isabel was given a written schedule at the start of her treatment but was now going “a bit slower.” 
 
 

Richard knew about reducing steroids as he had polymyalgia rheumatica (PMR) before vasculitis. This gives him “confidence” to use the schedule as a suggestion rather than a rule.

Richard knew about reducing steroids as he had polymyalgia rheumatica (PMR) before vasculitis. This gives him “confidence” to use the schedule as a suggestion rather than a rule.

Age at interview: 64
Sex: Male
Age at diagnosis: 64
GCA (with PMR)
SHOW TEXT VERSION
PRINT TRANSCRIPT

I have followed that, up to a point, it just, just over a month ago now, I was struggling to make the drop from ten milligrams to nine, so I’ve, I’ve returned to ten and, it’s one of the areas where my previous PMR experience I think makes things easier for me in that I have the, you might call it confidence to, deviate where appropriate from the prescribed path. It’s not being cavalier, it’s not deciding I know best and so on, but it’s just realising that the schedule that’s been mapped out is a suggestion. But I think as I said earlier, the disease will go at its own sweet pace and if that’s not tying in with the reduction in steroids you’ve got to be able to say, “No, just I can’t go down, let’s just stop here a bit.”

It’s a discretion that has to be used carefully, though, because you do read in the online sites about people who have quite a bit of trouble, if they play around with the doses too much you can end up with what they call yo-yoing and you, if you go up too quickly and then try and come down, the, the whole pattern of your inflammation I think can get disrupted, it never truly settles and you can end up with I think just more problems in the long term. I don’t know the details of why it happens but it’s very much the tone that I pick up from what I’m reading.

So, I think I, trying to be careful about it, don’t be too dramatic, give, give the aches and pains a chance to go away when they do appear because, when you do a drop down, say from ten to nine, the body may react just to the reduction in steroid, but they reckon that any impact of steroid withdrawal will go away after two, three, four days. So, I gave it two weeks before I said, “No, this is, this is lasting so let’s just go back up.”

 

Graham regrets trying to reduce his steroids so much, as his vasculitis suddenly relapsed.

Graham regrets trying to reduce his steroids so much, as his vasculitis suddenly relapsed.

Age at interview: 81
Sex: Male
Age at diagnosis: 71
GCA
SHOW TEXT VERSION
PRINT TRANSCRIPT

Since coming off the IV and the 60 milligram prednisolone tablets, I’ve tapered down, and I got down to about seven or eight. And then I thought – and then I chatted with this patient in [large city] and asked her how she was getting on, a few, a couple of years later. And she said, “Oh, I’ve got down to five.” I said, “Right, if she can get down to five, I can get down to five.”

I did take it very slowly, but I went down, slowly, half-milligrams. I went down to five. Up until then I’d had no relapses whatsoever, and suddenly within a couple of days I had a relapse. Severe headaches, recognisable, these headaches. Temple headaches.

And so, the doctor - I’d changed practice by then, practice in [town] - she got me straight, she got straight on to the rheumatology and they put me straight back on to 60 milligrams of oral prednisolone. And then I came down, tapering down again, and they said, “Whatever you do, don’t go below, below seven.” And I’d been told this by my rheumatologist, so it was my fault. Trying to be clever. So, I’ve been on seven now for some time and I’ve never had a relapse. Seven is a good place to be, actually.

 
It was common for people to remain on a low dose of steroids as part of their maintenance treatment, and they varied in how important they felt it was to come off steroids altogether. Nicola and Dawn had both wanted this desperately, whereas Richard said, “I want to come off steroids but I’m not in some hell for leather rush to get down to zero.” 
 
Almost everyone we spoke to told us that doctors had encouraged them to reduce their reliance on steroids by combining or gradually replacing them with other immunosuppressants. However, among those who have a type of vasculitis called giant cell arteritis (GCA), ideas about using these “steroid sparers” were mixed. 
 
 

Roberta is already on one “horrible” drug for vasculitis and doesn’t really want to go on to another.

Roberta is already on one “horrible” drug for vasculitis and doesn’t really want to go on to another.

Age at interview: 69
Sex: Female
Age at diagnosis: 68
GCA
SHOW TEXT VERSION
PRINT TRANSCRIPT

So basically, from then I’ve just been kind of up and down with the prednisolone, tapering, you know, it seems to be like every time I get down to ten milligrams or lower the, I start getting a bit headachy and the, the CRP goes up again, so I’ve got, I’ve been a bit up and down with that.

They’ve been trying from the, well the consultant’s been trying from the beginning to get me on to tocilizumab, which I think, I think that’s how you pronounce it, which is a, a drug that helps you get off the steroids quicker. But being me, I’m quite phobic about taking tablets and like I read all the, you know - it’s from previous experience - I read all the leaflets and you know, if I think the side effects are going to be bad, I just don’t take them; I’m a GP’s worst nightmare [smiles].

But the tocilizumab, when I read that it said it’s not recommended if you have diverticular disease because it can inflame it, so I’d mentioned that to her so she said, about methotrexate - which is a cancer drug which is scary in itself - and I didn’t like what that could do, plus you’ve got to have blood tests for your liver and you’d be on it for life and I just said, “I really don’t want to go on these other drugs, I feel as if, you know, why, you’re on a horrible drug and then you’ve got to go on to another horrible drug to get you off this horrible drug.”

But I feel as if I’ve been quite pressurised into taking these drugs and I just don’t want to take them. You know, I became quite upset and quite stressed about it because I thought, you know, “They, they’re the experts and, you know, am I doing the wrong thing by not, by refusing to take it?” So, I think they’ve kind of given up and they’re trying to support me just coming off the prednisolone by the tapering. But I’ve said, I’ve said to the, the consultant on Tuesday that, you know, if when I get down to below the ten milligrams again, and I start having problems that I would maybe consider going on these, one of these other horrible things, but….

 
Graham lost vision in one eye through GCA. Although his rheumatologist would like him to take methotrexate or tocilizumab “for my own good,” Graham is concerned in case this affects the sight in his other eye. Richard has not been offered steroid sparers and assumes this is because steroids are “incredibly cheap…simple, effective.” However, Isabel’s consultant encouraged her from the start to use methotrexate as well as steroids. 

Copyright © 2024 University of Oxford. All rights reserved.

Previous Page
Next Page